Chinese herbal medicine may improve outcomes after STEMI

CHICAGO — A drug derived from traditional Chinese medicine as an adjunct to guideline-directed therapy improved CV outcomes at 30 days and 1 year compared with placebo after revascularization, with no excess bleeding risk, a speaker reported.“Despite reperfusion and optimal medical therapy, patients with STEMI still face a high risk of in-hospital mortality, myocardial no-flow and

IJMS, Free Full-Text

Body mass index trajectories during mid to late life and risks of mortality and cardiovascular outcomes: Results from four prospective cohorts - eClinicalMedicine

Frontiers Progress in Traditional Chinese Medicine Against Respiratory Viruses: A Review

The traditional Chinese medicine that could become 'key treatment' for heart attacks, as study finds it lowers inflammation without adverse effects

Traditional Chinese Medicine: What You Need To Know

PDF) Chinese Herbal Medicines Might Improve the Long-Term Clinical Outcomes in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: Results of a Decision-Analytic Markov Model

2021 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association

High-Sensitivity Troponin I after Cardiac Surgery and 30-Day Mortality

Impacts of the hearing aid intervention on healthcare utilization and costs among middle-aged and older adults: results from a randomized controlled trial in rural China - The Lancet Regional Health – Western

PDF) Chinese Herbal Medicines Might Improve the Long-Term Clinical Outcomes in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: Results of a Decision-Analytic Markov Model

Traditional Chinese medicine Tongxinluo may improve heart health

Frontiers The Use of Chinese Yang/Qi-Invigorating Tonic Botanical Drugs/ Herbal Formulations in Ameliorating Chronic Kidney Disease by Enhancing Mitochondrial Function